Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „approved“
Suchtreffer
Begriffe & Kennungen
Abevmy · 4.8 · Bevacizumab is not approved for use in patients under the age of 18 years. In published literature reports, ca
Eintrag öffnenAbilify Maintena · 4.8 · Prolactin In clinical trials for the approved indications and in post-marketing data both increase and decreas
Eintrag öffnenAbilify Maintena · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify · 4.8 · 51 Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in
Eintrag öffnenAbilify · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAlymsys · 4.8 · Alymsys is not approved for use in patients under the age of 18 years. In published literature reports, cases
Eintrag öffnenAripiprazole Accord · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAripiprazole Sandoz · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAripiprazole Zentiva · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAvastin · 4.8 · Avastin is not approved for use in patients under the age of 18 years. In published literature reports, cases
Eintrag öffnenAvzivi · 4.8 · Bevacizumab is not approved for use in patients under the age of 18 years. In published literature reports, ca
Eintrag öffnenAybintio · 4.8 · Bevacizumab is not approved for use in patients under the age of 18 years. In published literature reports, ca
Eintrag öffnenBlitzima · 4.8 · The overall safety profile was consistent with the well-established safety profile for rituximab in approved a
Eintrag öffnenBlitzima · 4.8 · The safety profile of rituximab in PV was consistent with the established safety profile in other approved aut
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnen